x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the quarterly period ended | ||
OR | ||
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 76-0238453 | |
(State or other jurisdiction of incorporation | (IRS Employer Identification No.) | |
or organization) |
50 Spring Meadow Rd. | ||
Mount Kisco, NY | 10549 | |
(Address of principal executive offices) | (Zip Code) |
(914) 244-1777 |
(Registrant’s telephone number, including area code) |
Large accelerated filer ¨ | Accelerated filer ¨ | |||
Non-accelerated filer ¨ | Smaller reporting company x | |||
(do not check if a smaller reporting company) | ||||
Page | |||
Note about Forward-Looking Statements | 1 | ||
PART I. FINANCIAL INFORMATION | |||
Item 1. | Financial Statements | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | ||
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | ||
Item 4. | Controls and Procedures | ||
PART II. OTHER INFORMATION | |||
Item 1. | Legal Proceedings | ||
Item 1A. | Risk Factors | ||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | ||
Item 3. | Defaults Upon Senior Securities | ||
Item 4. | Mine Safety Disclosures | ||
Item 5. | Other Information | ||
Item 6. | Exhibits | ||
Signatures | |||
Exhibit Index |
March 31, 2014 | December 31, 2013 | ||||||||||||||
September 30, 2013 | December 31, 2012 | (unaudited) | |||||||||||||
(unaudited) | |||||||||||||||
ASSETS | |||||||||||||||
Current Assets | |||||||||||||||
Cash | $ | 46,652 | $ | 98,930 | $ | 36,409 | $ | 155,056 | |||||||
Trade accounts receivable | 11,311 | 49,690 | 116,584 | 77,475 | |||||||||||
Inventory | 120,045 | 63,378 | |||||||||||||
Legal settlement proceeds receivable | - | 132,000 | |||||||||||||
Inventory, net | 88,062 | 86,195 | |||||||||||||
Total Current Assets | 178,008 | 211,998 | 241,055 | 450,726 | |||||||||||
Furnishings and equipment | 114,966 | 157,697 | |||||||||||||
Furnishings and equipment, net | 86,479 | 100,723 | |||||||||||||
Total Assets | $ | 292,974 | $ | 369,695 | $ | 327,534 | $ | 551,449 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
Current Liabilities | |||||||||||||||
Accounts payable and accrued expenses | $ | 207,283 | $ | 187,096 | $ | 190,686 | $ | 185,362 | |||||||
Advance payable | 10,200 | - | |||||||||||||
Deposit payable | - | 100,000 | |||||||||||||
Notes payable to officers | 28,200 | 40,200 | |||||||||||||
Total Current Liabilities | 217,483 | 187,096 | 218,886 | 325,562 | |||||||||||
Deferred tax liability | 34,700 | 47,600 | 26,100 | 30,400 | |||||||||||
Total Liabilities | 252,183 | 234,696 | 244,986 | 355,962 | |||||||||||
Stockholders’ equity | |||||||||||||||
Common stock, $0.01 par value; 50,000,000 shares authorized, 29,409,973 shares issued and outstanding at September 30, 2013 | 294,099 | 289,099 | |||||||||||||
Common stock, $0.01 par value; 50,000,000 shares authorized, 30,204,973 shares issued and outstanding at March 31, 2014 | 302,049 | 301,049 | |||||||||||||
Additional paid-in capital | 7,738,999 | 7,641,499 | 7,985,299 | 7,958,299 | |||||||||||
Accumulated (deficit) | (7,992,307) | (7,795,599) | (8,204,800 | ) | (8,063,861 | ) | |||||||||
Total Stockholders’ Equity | 40,791 | 134,999 | 82,548 | 195,487 | |||||||||||
Total Liabilities and Stockholders’ Equity | $ | 292,974 | $ | 369,695 | $ | 327,534 | $ | 551,449 |
Three Months Ended March 31 | ||||||||
2014 | 2013 | |||||||
Sales | $ | 192,429 | $ | 230,258 | ||||
Cost of sales | 49,090 | 52,900 | ||||||
Gross Profit | 143,339 | 177,358 | ||||||
Compensation and related expenses | (164,021 | ) | (119,891 | ) | ||||
Professional fees | (54,593 | ) | (46,741 | ) | ||||
General and administrative expenses | (102,363 | ) | (81,513 | ) | ||||
Operating (Loss) | (177,638 | ) | (70,787 | ) | ||||
License Fee | 25,000 | 25,000 | ||||||
Other income | 7,877 | - | ||||||
Interest (expense) | (478 | ) | - | |||||
Net (Loss) Before Taxes | (145,239 | ) | (45,787 | ) | ||||
Deferred income tax benefit | 4,300 | 4,300 | ||||||
Net (Loss) | $ | (140,939 | ) | $ | (41,487 | ) | ||
Basic and diluted (loss) per share | $ | (0.00 | ) | $ | (0.00 | ) | ||
Average number of common shares outstanding | 30,171,640 | 28,909,973 |
Additional | ||||||||||||||||||||
Common Stock | Paid-in | Accumulated | ||||||||||||||||||
Shares | Amount | Capital | (Deficit) | Total | ||||||||||||||||
Balance at December 31, 2013 | 30,104,973 | $ | 301,049 | $ | 7,958,299 | $ | (8,063,861 | ) | $ | 195,487 | ||||||||||
Issuance of common stock for services | 100,000 | 1,000 | 27,000 | - | 28,000 | |||||||||||||||
Net (loss) | - | - | - | (140,939 | ) | (140,939 | ) | |||||||||||||
Balance at March 31, 2014 | 30,204,973 | $ | 302,049 | $ | 7,985,299 | $ | (8,204,800 | ) | $ | 82,548 |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||
Sales | $ | 94,676 | $ | 152,115 | $ | 647,837 | $ | 558,218 | |||||
Cost of sales | 17,475 | 53,854 | 124,181 | 190,778 | |||||||||
Gross Profit | 77,201 | 98,261 | 523,656 | 367,440 | |||||||||
Compensation and related expenses | (102,166) | (104,668) | (380,154) | (329,641) | |||||||||
Professional fees | (20,129) | (71,827) | (104,157) | (175,344) | |||||||||
General and administrative expenses | (123,572) | (85,406) | (298,953) | (277,630) | |||||||||
Operating (Loss) | (168,666) | (163,641) | (259,608) | (415,175) | |||||||||
License Fee | 25,000 | - | 50,000 | 25,000 | |||||||||
Other income | - | - | - | 6,161 | |||||||||
Interest (expense) | - | - | - | (3,371) | |||||||||
Net (Loss) Before Taxes | (143,666) | (163,641) | (209,608) | (387,385) | |||||||||
Deferred income tax benefit | 4,300 | 4,300 | 12,900 | 12,900 | |||||||||
Net (Loss) | $ | (139,366) | $ | (159,341) | $ | (196,708) | $ | (374,485) | |||||
Basic and diluted (loss) per share | $ | (0.00) | $ | (0.01) | $ | (0.01) | $ | (0.01) | |||||
Average number of common shares outstanding | 29,410,000 | 28,890,500 | 29,194.500 | 27,061,000 |
Additional | |||||||||||||||
Common Stock | Paid-in | Accumulated | |||||||||||||
Shares | Amount | Capital | (Deficit) | Total | |||||||||||
Balance at December 31, 2012 | 28,909,973 | $ | 289,099 | $ | 7,641,499 | $ | (7,795,599) | $ | 134,999 | ||||||
Stock options exercised | 500,000 | 5,000 | 45,000 | - | 50,000 | ||||||||||
Amortization of stock options | - | - | 52,500 | - | 52,500 | ||||||||||
Net (loss) | - | - | - | (196,708) | (196,708) | ||||||||||
Balance at September 30, 2013 | 29,409,973 | $ | 294,099 | $ | 7,738,999 | $ | (7,992,307) | $ | 40,791 |
Three Months Ended March 31 | ||||||||
2014 | 2013 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net (Loss) | $ | (140,939 | ) | $ | (41,487 | ) | ||
Adjustments to reconcile net (loss) to net cash (used) by operating activities | ||||||||
Depreciation | 14,244 | 14,244 | ||||||
Deferred tax benefit | (4,300 | ) | (4,300 | ) | ||||
Stock compensation expense | 28,000 | 27,000 | ||||||
Changes in Assets And Liabilities | ||||||||
Trade accounts receivable | (39,109 | ) | (64,151 | ) | ||||
Legal settlement proceeds receivable | 132,000 | |||||||
Inventory | (1,867 | ) | (5,398 | ) | ||||
Accounts payable and accrued expenses | 5,324 | 14,079 | ||||||
Net cash (used) by operating activities | (6,647 | ) | (60,013 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Investment in Adiuvo Investment S. A. | (100,000 | ) | - | |||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Repayment of note payable | (12,000 | ) | - | |||||
Net (decrease) in cash | (118,647 | ) | (60,013 | ) | ||||
Cash at beginning of the period | 155,056 | 98,930 | ||||||
Cash at end of the period | $ | 36,409 | $ | 38,917 |
Nine Months Ended September 30 | |||||||
2013 | 2012 | ||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
Net (Loss) | $ | (196,708) | $ | (374,485) | |||
Adjustments to reconcile net (loss) to net cash (used) by operating activities | |||||||
Depreciation | 42,731 | 42,444 | |||||
Deferred tax benefit | (12,900) | (12,900) | |||||
Stock compensation expense | 52,500 | 71,500 | |||||
Common stock issued for services | - | 119,000 | |||||
Changes in Assets And Liabilities | |||||||
Trade accounts receivable | 38,379 | (42,944) | |||||
Inventory | (56,667) | 21,856 | |||||
Accounts payable and accrued expenses | 20,187 | 10,056 | |||||
Net cash (used) by operating activities | (112,478) | (165,473) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
Exercise of stock options | 50,000 | - | |||||
Issuance of common stock | - | 345,883 | |||||
Notes and advance payable | 10,200 | (50,729) | |||||
Net cash provided by financing activities | 60,200 | 295,154 | |||||
Net (decrease) increase in cash | (52,278) | 129,681 | |||||
Cash at beginning of the period | 98,930 | 33,502 | |||||
Cash at end of the period | $ | 46,652 | $ | 163,183 | |||
Supplemental Schedule of Non-Cash Investing and Financing Activities | |||||||
Cash paid during the period for interest | $ | - | $ | 3,371 | |||
Notes payable and other payables used to exercise options and warrants | $ | - | $ | 311,443 |
|
|
|
|
Basis of Presentation and Use of Estimates The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the valuation of stockholders’ equity based transactions. Actual results could differ from those estimates. Reclassification Certain amounts in the prior period have been reclassified to conform to the current period presentation. Inventory Inventory is valued at the lower of cost or market with cost determined on a first-in, first-out (“FIFO”) basis. Management compares the cost of inventory with the net realizable value and an allowance is made for writing down inventory to market value, if lower. Inventory consists of the following:
Revenue Recognition The Company’s policy is to record revenue as earned when a firm commitment, indicating sales quantity and price exists, delivery has taken place and collectability is reasonably assured. The Company generally records sales once the product is shipped to the customer. If applicable, provisions for discounts, returns, allowances, customer rebates and other adjustments are netted with gross sales. The Company accounts for such provisions during the same period in which the related revenues are earned. Customer discounts, returns and rebates have not been significant. Delivery is considered to have occurred when title and risk of loss have transferred to the customer. Sales to international distributors are recognized in the same manner. If title does not pass until the product reaches the customer’s delivery site, then recognition of revenue is deferred until that time. There are no formal sales incentives offered to any of the Company’s customers. Volume discounts may be offered from time to time to customers purchasing large quantities on a per transaction basis. There are no special post shipment obligations or acceptance provisions that exist with any sales arrangements. | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
September 30, 2013 | December 31, 2012 | ||||||
Raw materials | $ | 17,125 | $ | 12,800 | |||
Work in process | 33,949 | - | |||||
Finished products | 68,971 | 50,578 | |||||
$ | 120,045 | $ | 63,378 |
| |
Income Taxes The Company records current and deferred taxes in accordance with Accounting Standards Codification (ASC) 740, “Accounting for Income Taxes.” This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. The Company periodically assesses the value of its deferred tax asset, a majority of which has been generated by a history of net operating losses and determines the necessity for a valuation allowance. ASC 740 also provides a recognition threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken in a tax return. Using this guidance, a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is more likely-than-not (i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company’s tax returns for all years since December 31, 2010, remain open to most taxing authorities. Stock-Based Compensation The Company follows the provisions of ASC 718, “Share-Based Payment”. Under this guidance compensation cost generally is recognized at fair value on the date of the grant and amortized over the respective vesting periods. The fair value of options at the date of grant is estimated using the Black-Scholes option pricing model. The expected option life is derived from assumed exercise rates based upon historical exercise patterns and represents the period of time that options granted are expected to be outstanding. The expected volatility is based upon historical volatility of the Company’s shares using weekly price observations over an observation period that approximates the expected life of the options. The risk-free rate approximates the U.S. Treasury yield curve rate in effect at the time of grant for periods similar to the expected option life. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense. Earnings (Loss) Per Share |
|
| |
| |
Basic earnings (loss) per common share is based on the weighted average number of shares outstanding during each period presented. Warrants and options to purchase common stock are included as common stock equivalents only when dilutive. Potential common stock equivalents are excluded from dilutive earnings per share when the effects would be antidilutive. |
Recent Accounting Pronouncements Accounting standards that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. Fair Value of Financial Instruments The carrying value of the Company’s financial instruments, including cash, trade accounts receivable and accounts payable and accrued expenses and notes payable approximate fair value for all periods. Concentration of Credit Risk The Company grants credit in the normal course of business to its customers. The Company periodically performs credit analysis and monitors the financial condition of its customers to reduce credit risk. The Company monitors its positions with, and the credit quality of, the financial institutions with which it invests. The Company, at times, maintains balances in various operating accounts in excess of federally insured limits. One customer accounted for 92% and 77% of sales for the three month periods ended March 31, 2014 and 2013, respectively. At March 31, 2014 and December 31, 2013, this customer accounted for 99% and 70% of accounts receivable, respectively. A second customer accounted for 11% of sales for three month period ended March 31, 2013. At December 31, 2013 this customer accounted for 28% of accounts receivable. 3. Joint Venture Agreement In December 2013 the Company entered into a memorandum of understanding (MOU) with Adiuvo Investment S.A. (AI), an investment company located in Poland, whereby AI paid the Company $100,000 for the option, expiring in September 2014, to purchase up to 10% of the outstanding stock in the Company at $0.25 per share. Upon the acquisition of the Company’s stock, AI also has the right to acquire, pro-rata to the number of shares purchased by AI, warrants to purchase up to 1,472,000 shares, exercisable at $0.22 per share for three years from the date of the MOU. AI also has the right to acquire additional warrants upon the Company achieving certain financial milestones. At December 31, 2013, the Company has reported a $100,000 deposit payable, which is included in the accompanying balance sheet. | |
| |
4. Notes Payable At March 31, 2014, notes payable are due to officers and directors and are payable on demand with interest at 5%. A summary of notes payable activity is as follows:
Interest expense on notes payable amounted to $478 and $0 for for the three month periods ended March 31, 2014 and 2013, respectively. 5. Income Taxes The Company incurred a loss for the three month periods ended March 31, 2014 and 2013 and accordingly, no provision for federal income tax has been made in the accompanying financial statements. At December 31, 2013, the Company had available net operating loss carryforwards of approximately $2,650,000, expiring during various years through 2033. A summary of the deferred tax asset using an approximate 34% tax rate is as follows:
The net operating loss carryforwards could be subject to limitation in any given year in the event of a change in ownership as defined by IRC Section 382. The deferred tax liability of $26,100 and $34,400 at at March 31, 2014 and December 31, 2013, respectively, results from the difference in the carrying amount of furnishings and equipment between financial reporting and income tax reporting. The deferred tax benefit included in the statement of operations represents the change in the deferred tax liability at each balance sheet date. The difference between the statutory and the effective tax rate is primarily due to a change in valuation allowance on deferred taxes, as the Company has fully reserved the deferred tax asset resulting from available net operating loss carryforwards. 10 | ||||||||||||||||||||||||||||||||||||||||||||||
December 31, 2012 | ||||
Net operating loss | $ | 870,000 | ||
Valuation allowance | (870,000) | |||
Total | $ | - |
6. Stockholders’ Equity Service-Based Stock Options Service-based options issued by the Company to various employees and consultants amounted to 9,885,000 at December 31, 2013 and March 31, 2014. In January 2014 the Company issued 100,000 shares of restricted common stock, valued at $28,000 to a consultant.. Stock based compensation expense amounted to $0 and $27,000 for the three months ended March 31, 2014 and 2013, respectively. Such amounts are included in compensation and related expenses in the accompanying statement of operations. Options exercisable at March 31, 2014 amounted to 9,835,000. All outstanding options have a cashless exercise provision, and certain options provide for accelerated vesting provisions and modifications, as defined, if the Company is sold or acquired. The intrinsic value of options outstanding and exercisable at March 31, 2014 amounted to $350,500. The following is a summary of outstanding service-based options at March 31, 2014:
Performance-Based Stock Options As of March 31, 2014 the Company granted performance-based options to purchase 6,950,000 shares of common stock at exercise prices ranging from $0.40 to $5,00. The options expire at various dates between 2021 and 2023 and are exercisable upon the Company achieving annual sales revenue ranging from $5,000,000 to $100,000,000. The fair value of these performance-based options aggregated $302,000 and will be expensed over the implicit service period commencing once management believes the performance criteria will be met. Accordingly, at March 31, 2014, the unearned compensation for performance based options is $302,000. 11 | |||||||||||||||||||||||||||||||||||||||||||||||||
Exercise Price | Number of Options | Weighted Average Remaining Contractual Life | ||||
$0.10 | $ | 1,000,000 | 5 years | |||
$0.13 - $0.20 | 7,560,000 | 9 years | ||||
$0.40 | 1,000,000 | 9 years | ||||
Total | $ | 9,560,000 |
7. Royalties The Company is subject to a royalty agreement based upon sales of certain skin care products. The agreement requires the Company to pay a royalty based upon 8% of such sales, up to $227,175. Royalty expense approximated $14,000 for each of the three month periods ended March 31, 2014 and 2013, respectively. The remaining commitment at March 31, 2014, is approximately $51,000. The Company’s President has a 60% interest in the royalties. At March 31, 2014 and December 31, 2013, included in accounts payable and accrued expenses was $102,000 and $88,000, respectively, in regards to this agreement. 8. Commitments and Contingencies Leases The Company leases a plant in Kentucky under an operating lease which expires May 31, 2016. Future minimum base rental payments required under the lease are as follows:
Monthly base rental payments approximate $3,400. The lease agreement also provides for additional rents based on increases in building operating costs and real estate taxes. Rent expense for the three month periods ended March 31, 2014 and 2013, was $14,626 and $10,234, respectively. 12 | |||||||||||||||||||||||||||||||
Year ending December 31 | ||||
2013 (3 months) | $ | 10,240 | ||
2014 | 41,675 | |||
2015 | 42,187 | |||
2016 | 17,578 | |||
Total | $ | 111,680 |
2014 | 2013 | |||||||||||||||
$ | % of Sales | $ | % of Sales | |||||||||||||
Sales | 192,429 | - | 230,258 | - | ||||||||||||
Cost of sales | 49,090 | 25.5 | % | 52,900 | 23.0 | % | ||||||||||
Gross profit | 143,339 | 74.5 | % | 177,358 | 77.0 | % | ||||||||||
Operating expenses | (320,977 | ) | (167 | ) % | (248,145 | ) | (107.8 | ) % | ||||||||
Loss from operations | (177,638 | ) | (92.5 | ) % | (70,787 | ) | (30.8 | ) % | ||||||||
Other income | 32,399 | 16.8 | % | 25,000 | 10.9 | % | ||||||||||
Income tax benefit | 4,300 | 2.5 | % | 4,300 | 1.9 | % | ||||||||||
Net loss | (140,939 | ) | (73.2 | ) % | (41,487 | ) | (18.0 | ) % |
2013 | 2012 | |||||||||||||
$ | % of Sales | $ | % of Sales | |||||||||||
Sales | 94,676 | - | 152,115 | |||||||||||
Cost of sales | 17,475 | 18.5 | % | 53,854 | 35.4 | % | ||||||||
Gross profit | 77,201 | 81.5 | % | 98,261 | 64.6 | % | ||||||||
Operating expenses | (245,867) | (259.7) | % | (261,901) | (172.2) | % | ||||||||
Loss from operations | (168,666) | (178.2) | % | (163,641) | (107.6) | % | ||||||||
Other income | 25,000 | 26.4 | % | - | - | % | ||||||||
Income tax benefit | 4,300 | 4.5 | % | 4,300 | 2.8 | % | ||||||||
Net loss | (139,366) | (147.2) | % | (159,341) | (104.8) | % |
2013 | 2012 | |||||||||||||
$ | % of Sales | $ | % of Sales | |||||||||||
Sales | 647,837 | 558,218 | ||||||||||||
Cost of sales | 124,181 | 19.2 | % | 190,778 | 34.2 | % | ||||||||
Gross profit | 523,656 | 80.8 | % | 367,440 | 65.8 | % | ||||||||
Operating expenses | (783,264) | (120.9) | % | (782,615) | (140.2) | % | ||||||||
Loss from operations | (259,608) | (40.1) | % | (415,175) | (74.4) | % | ||||||||
Other income | 50,000 | 7.7 | % | 31,161 | 6.0 | % | ||||||||
Interest (expense) | - | - | % | (3,371) | (1.0) | % | ||||||||
Income tax benefit | 12,900 | 2.0 | % | 12,900 | 2.3 | % | ||||||||
Net loss | (196,708) | (30.4) | % | (374,485) | (67.1) | % |
2013 | 2012 | 2014 | 2013 | ||||||||||||
Cash provided by (used in): | |||||||||||||||
Operating activities | $ | (112,478) | (165,473) | $ | (6,647 | ) | $ | (60,013 | ) | ||||||
Financing activities | 60,200 | 295,154 | (12,000 | ) | - |
IMMUDYNE INC. | |||
(Registrant) | |||
Date: | By: | /s/ Mark McLaughlin | |
Mark McLaughlin | |||
Chief Executive Officer | |||
(Principal Executive Officer) |
Exhibit No. | Document Description | |
31.1† | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1‡ | Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS† | XBRL Instance Document | |
XBRL Schema Document | ||
XBRL Calculation Linkbase Document | ||
XBRL Definition Linkbase Document | ||
XBRL Label Linkbase Document | ||
XBRL Presentation Linkbase Document |